Eric Topol, Date of Birth, Place of Birth

    

Eric Topol

American cardiologist

Date of Birth: 26-Jun-1954

Place of Birth: Rochester, New York, United States

Profession: geneticist, cardiologist

Nationality: United States

Zodiac Sign: Cancer

Social Profiles:

Show Famous Birthdays Today, United States

👉 Worldwide Celebrity Birthdays Today

About Eric Topol

  • Eric Jeffrey Topol (born 1954) is an American cardiologist, geneticist, and digital medicine researcher.
  • Before moving to Scripps in 2006, Topol served as chairman of cardiovascular medicine at Cleveland Clinic (1991-2005).
  • Topol was one of the first researchers to question the cardiovascular safety of rofecoxib (Vioxx), culminating in the drug's ultimate withdrawal from the market.
  • Topol's advocacy on the subject led to what The New York Times described as an "unusually public dispute" with the Cleveland Clinic's leadership over ties between the academic institution and the pharmaceutical industry, ultimately leading to Topol's departure from the Clinic after his administrative position as head of the Clinic's academic program was abolished. Topol is the Founder and Director of the Scripps Research Translational Institute in La Jolla, California.
  • He also serves as the Chief Academic Officer for Scripps Health, a Professor of Genomics at The Scripps Research Institute, and a Senior Consultant at the Division of Cardiovascular Diseases at Scripps Clinic.
  • He is editor-in-chief of Medscape and theheart.org.
  • In 2012, he published a book called The Creative Destruction of Medicine which examined the impact of both the genomic and wireless revolutions on the health care system.
  • His book The Patient Will See You Now, published in 2015, explores how smartphones, big data, and technology are combining to democratize health care.
  • In 2016, Topol co-founded a company developing an individual-centric health data platform.
  • In 2019, he wrote the book Deep Medicine, which focuses on how AI empowers physicians and revolutionizes the health care industry.In 2016, Topol was awarded a $207M grant from the National Institutes of Health to lead a significant part of the Precision Medicine Initiative, a one million American prospective research program.

Read more at Wikipedia

See Also